Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 33.5B | 35.7B | 33.3B | 32.8B |
| Cost of revenue | 13.1B | 15.5B | 13.2B | 12.5B |
| Gross profit | 20.4B | 20.2B | 20.1B | 20.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 7.9B | 8.2B | 9.7B | 8.0B |
| Other operating expenses | — | — | — | — |
| Operating income | 8.0B | 7.4B | 5.9B | 7.8B |
| Non operating interest income | ||||
| Income | 63M | 78M | 97M | 83M |
| Expense | 1.6B | 1.6B | 1.7B | 1.7B |
| Other income expense | 64M | 713M | -49M | -169M |
| Pretax income | 6.5B | 6.6B | 4.3B | 6.0B |
| Tax provision | 1.5B | 1.5B | 891M | 1.3B |
| Net income | 5.0B | 5.1B | 3.4B | 4.7B |
| Basic EPS | 1.2 | 1.2 | 0.8 | 1.1 |
| Diluted EPS | 1.2 | 1.2 | 0.8 | 1.1 |
| Basic average shares | 4.7B | 4.7B | 4.7B | 4.7B |
| Diluted average shares | 4.7B | 4.7B | 4.7B | 4.7B |
| EBITDA | 12.6B | 12.6B | 10.3B | 12.1B |
| Net income from continuing op. | 5.0B | 5.1B | 3.4B | 4.7B |
| Minority interests | -104M | -109M | -105M | -109M |
| Preferred stock dividends | — | — | — | — |